Biotechnology Companies By Ps Ratio

Price To Sales
Price To SalesEfficiencyMarket RiskExp Return
1NKTX NkartaInc
1000000.0
 0.25 
 12.07 
 3.01 
2IMRX Immuneering Corp
398832.0
(0.07)
 5.21 
(0.34)
3ACIU AC Immune
359637.0
 0.05 
 4.76 
 0.24 
4SVRA Savara Inc
131146.0
 0.16 
 2.97 
 0.46 
5EDSA Edesa Biotech
120478.0
 0.12 
 5.45 
 0.66 
6TIL Instil Bio
55329.79
 0.24 
 4.21 
 1.02 
7BTTX Better Therapeutics
49559.41
 0.00 
 7.68 
 0.01 
8ABVX Abivax SA American
35265.26
 0.16 
 3.16 
 0.51 
9SPRY Silverback Therapeutics
28863.16
 0.25 
 3.33 
 0.85 
10OCGN Ocugen Inc
25069.32
 0.23 
 7.30 
 1.71 
11DSGN Design Therapeutics
22642.01
 0.08 
 3.04 
 0.25 
12KRTX Karuna Therapeutics
18405.97
 0.15 
 6.26 
 0.92 
13KROS Keros TherapeuticsInc
16719.3
 0.28 
 5.02 
 1.39 
14KZIA Kazia Therapeutics
12116.79
(0.12)
 5.88 
(0.73)
15CVM CEL SCI Corp
11797.42
(0.10)
 4.12 
(0.41)
16ALXO Alx Oncology Holdings
5906.24
 0.18 
 6.53 
 1.15 
17IBRX Immunitybio
5799.09
 0.09 
 7.89 
 0.73 
18LYEL Lyell Immunopharma
5704.29
 0.17 
 4.80 
 0.83 
19PMN ProMIS Neurosciences
5168.19
 0.15 
 9.16 
 1.37 
20ALLO Allogene Therapeutics
4632.14
 0.24 
 5.11 
 1.22 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries. The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.